Atlas Trials

Study to Assess the Safety and Tolerability After Multiple Oral Doses of AZD1656 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

Clinical trial NCT00817778 · COMPLETED

Trial details

NCT number
NCT00817778
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Type 2 Diabetes
Start date
2009-01-01
Primary completion
2009-07-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.